参考文献/References:
[1]Tomley F M, Shirley M W. Livestock infectious diseases and zoonoses[J]. Philosophical Transactions of the Royal Society B-Biological Sciences,2009,364(1530):2637-2642.
[2]Zhou L, Han J, Yang H C. The evolution and diversity of porcine reproductive and respiratory syndrome virus in China[J]. Veterinary Microbiology,2024,298:110252.
[3]Maes D, Sibila M, Kuhnert P, et al. Update on Mycoplasma hyopneumoniae infections in pigs:knowledge gaps for improved disease control[J]. Transboundary and Emerging Diseases,2018,65(S1):110-124.
[4]Naguib M M, Verhagen J H, Mostafa A, et al. Global patterns of avian influenza A (H7):virus evolution and zoonotic threats[J]. FEMS Microbiology Reviews,2019,43(6):608-621.
[5]Kamel M S, Davidson J L, Verma M S. Strategies for bovine respiratory disease (BRD) diagnosis and prognosis:a comprehensive overview[J]. Animals (Basel),2024,14(4):627.
[6]杨汉春,周磊. 2024年猪病流行情况与2025年流行趋势及防控对策[J]. 猪业科学,2025,42(2):54-57.
[7]Kesheh M M, Hosseini P, Soltani S, et al. An overview on the seven pathogenic human coronaviruses[J]. Reviews in Medical Virology,2022,32(2):e2282.
[8]中国医院协会临床微生物实验室专业委员会. 新发突发呼吸道传染性病原微生物分级检测专家共识(2024)[J]. 协和医学杂志,2025,16(1):109-124.
[9]France M M, Turner J R. The mucosal barrier at a glance[J]. Journal of Cell Science,2017,130(2):307-314.
[10]Li X Y, Chen M H, Chen T T, et al. The intricate interplay among microbiota, mucosal immunity, and viral infection in the respiratory tract[J]. Journal of Translational Medicine,2025,23(1):488.
[11]Zanin M, Baviskar P, Webster R, et al. The interaction between respiratory pathogens and mucus[J]. Cell Host & Microbe,2016,19(2):159-168.
[12]Adivitiya, Kaushik M S, Chakraborty S, et al. Mucociliary respiratory epithelium integrity in molecular defense and susceptibility to pulmonary viral infections[J]. Biology (Basel),2021,10(2):95.
[13]Li Y, Tang X X. Abnormal airway mucus secretion induced by virus infection[J]. Frontiers in Immunology,2021,12:701443.
[14]Singanayagam A, Footitt J, Marczynski M, et al. Airway mucins promote immunopathology in virus-exacerbated chronic obstructive pulmonary disease[J]. The Journal of Clinical Investigation,2022,132(8):e120901.
[15]Wallace L E, Liu M Y, Van Kuppeveld F J M, et al. Respiratory mucus as a virus-host range determinant[J]. Trends in Microbiology,2021,29(11):983-992.
[16]Button B, Cai L H, Ehre C, et al. A periciliary brush promotes the lung health by separating the mucus layer from airway epithelia[J]. Science,2012,337(6097):937-941.
[17]Fahy J V, Dickey B F. Airway mucus function and dysfunction[J]. The New England Journal of Medicine,2010,363(23):2233-2247.
[18]Whitsett J A. Airway epithelial differentiation and mucociliary clearance[J]. Annals of the American Thoracic Society,2018,15(S3):S143-S148.
[19]Ridley C, Thornton D J. Mucins:the frontline defence of the lung[J]. Biochemical Society Transactions,2018,46(5):1099-1106.
[20]Chatterjee M, Van Putten J P M, Strijbis K. Defensive properties of mucin glycoproteins during respiratory infections-relevance for SARS-CoV-2[J]. mBio,2020,11(6). DOI:10.1128/mB-10.02374-20.
[21]Hovenberg H W, Davies J R, Carlstedt I. Different mucins are produced by the surface epithelium and the submucosa in human trachea:identification of MUC5AC as a major mucin from the goblet cells[J]. The Biochemical Journal,1996,318(1):319-324.
[22]Haberman M, Kamyshinsky R, Reznik N, et al. MUC5AC filaments illuminate the structural diversification of respiratory and intestinal mucins[J]. Proceedings of the National Academy of Sciences of the United States of America,2025,122(10):e2419717122.
[23]Hansson G C. Mucins and the microbiome[J]. Annual Review of Biochemistry,2020,89:769-793.
[24]Symmes B A, Stefanski A L, Magin C M, et al. Role of mucins in lung homeostasis:regulated expression and biosynthesis in health and disease[J]. Biochemical Society Transactions,2018,46(3):707-719.
[25]Chatterjee M, Huang L Z X, Mykytyn A Z, et al. Glycosylated extracellular mucin domains protect against SARS-CoV-2 infection at the respiratory surface[J]. PLoS Pathogens,2023,19(8):e1011571.
[26]Linden S K, Sutton P, Karlsson N G, et al. Mucins in the mucosal barrier to infection[J]. Mucosal Immunology,2008,1(3):183-197.
[27]Ehre C, Worthington E N, Liesman R M, et al. Overexpressing mouse model demonstrates the protective role of MUC5AC in the lungs[J]. Proceedings of the National Academy of Sciences of the United States of America,2012,109(41):16528-16533.
[28]Wagner C E, Wheeler K M, Ribbeck K. Mucins and their role in shaping the functions of mucus barriers[J]. Annual Review of Cell and Developmental Biology,2018,34:189-215.
[29]Wheeler K M, Carcamo-Oyarce G, Turner B S, et al. Mucin glycans attenuate the virulence of Pseudomonas aeruginosa in infection[J]. Nature Microbiology,2019,4(12):2146-2154.
[30]Bath J, Bjanes E, Goekeri C, et al. Mucins protect against Streptococcus pneumoniae virulence by suppressing pneumolysin expression[J]. The Journal of Clinical Investigation,2024,134(19):e182769.
[31]Co J Y, Carcamo-Oyarce G, Billings N, et al. Mucins trigger dispersal of Pseudomonas aeruginosa biofilms[J]. NPJ Biofilms and Microbiomes,2018,4:23.
[32]Hill D B, Button B, Rubinstein M, et al. Physiology and pathophysiology of human airway mucus[J]. Physiological Reviews,2022,102(4):1757-1836.
[33]Kim C H, Oh Y, Han K, et al. Expression of secreted and membrane-bound mucins in the airways of piglets experimentally infected with Mycoplasma hyopneumoniae[J]. Veterinary Journal,2012,192(1):120-122.
[34]Kim C H, Oh Y, Han K, et al. Expression of secreted mucins (MUC2, MUC5AC, MUC5B, and MUC6) and membrane-bound mucin (MUC4) in the lungs of pigs experimentally infected with Actinobacillus pleuropneumoniae[J]. Research in Veterinary Science,2012,92(3):486-491.
[35]Zhao X, Yang J J, Zhuo C, et al. PRRSV disrupted nasal mucosal homeostasis by initiating Notch signaling to induce goblet cell differentiation[J]. Veterinary Microbiology,2025,311:110774.
[36]Hong J Y, Bentley J K, Chung Y, et al. Neonatal rhinovirus induces mucous metaplasia and airways hyperresponsiveness through IL-25 and type 2 innate lymphoid cells[J]. The Journal of Allergy and Clinical Immunology,2014,134(2):429-439.
[37]Rajan D, O′Keefe E L, Travers C, et al. MUC5AC levels associated with respiratory syncytial virus disease severity[J]. Clinical Infectious Diseases,2018,67(9):1441-1444.
[38]Barbier D, Garcia-Verdugo I, Pothlichet J, et al. Influenza A induces the major secreted airway mucin MUC5AC in a protease-EGFR-extracellular regulated kinase-Sp1-dependent pathway[J]. American Journal of Respiratory Cell and Molecular Biology,2012,47(2):149-157.
[39]He J P, Cai S J, Feng H J, et al. Single-cell analysis reveals bronchoalveolar epithelial dysfunction in COVID-19 patients[J]. Protein & Cell,2020,11(9):680-687.
[40]Carpenter J, Wang Y, Gupta R, et al. Assembly and organization of the N-terminal region of mucin MUC5AC:indications for structural and functional distinction from MUC5B[J]. Proceedings of the National Academy of Sciences of the United States of America,2021,118(39):e2104490118.
[41]Yan F G, Li W, Jono H, et al. Reactive oxygen species regulate Pseudomonas aeruginosa lipopolysaccharide-induced MUC5AC mucin expression via PKC-NADPH oxidase-ROS-TGF-alpha signaling pathways in human airway epithelial cells[J]. Biochemical and Biophysical Research Communications,2008,366(2):513-519.
[42]Li J Y, Ye Z G. The potential role and regulatory mechanisms of MUC5AC in chronic obstructive pulmonary disease[J]. Molecules,2020,25(19):4437.
[43]Choi W, Choe S, Lau G W. Inactivation of FOXA2 by respiratory bacterial pathogens and dysregulation of pulmonary mucus homeostasis[J]. Frontiers in Immunology,2020,11:515.
[44]Lukacs N W, Smit J J, Mukherjee S, et al. Respiratory virus-induced TLR7 activation controls IL-17-associated increased mucus via IL-23 regulation[J]. Journal of Immunology,2010,185(4):2231-2239.
[45]Mukherjee S, Lindell D M, Berlin A A, et al. IL-17-induced pulmonary pathogenesis during respiratory viral infection and exacerbation of allergic disease[J]. The American Journal of Pathology,2011,179(1):248-258.
[46]Liu T, Zhou Y T, Wang L Q, et al. NOD-like receptor family, pyrin domain containing 3 (NLRP3) contributes to inflammation, pyroptosis, and mucin production in human airway epithelium on rhinovirus infection[J]. The Journal of Allergy and Clinical Immunology,2019,144(3):777-787.
[47]Hewson C A, Haas J J, Bartlett N W, et al. Rhinovirus induces MUC5AC in a human infection model and in vitro via NF-kappaB and EGFR pathways[J]. The European Respiratory Journal,2010,36(6):1425-1435.
[48]Hao Y H, Kuang Z Z, Jing J, et al. Mycoplasma pneumoniae modulates STAT3-STAT6/EGFR-FOXA2 signaling to induce overexpression of airway mucins[J]. Infection and Immunity,2014,82(12):5246-5255.
[49]Chu H W, Jeyaseelan S, Rino J G, et al. TLR2 signaling is critical for Mycoplasma pneumoniae-induced airway mucin expression[J]. Journal of Immunology,2005,174(9):5713-5719.
[50]Liu Y Y, Lü J, Liu J N, et al. Mucus production stimulated by IFN-AhR signaling triggers hypoxia of COVID-19[J]. Cell Research,2020,30(12):1078-1087.
[51]Mata M, Morcillo E, Gimeno C, et al. N-acetyl-L-cysteine (NAC) inhibit mucin synthesis and pro-inflammatory mediators in alveolar type Ⅱ epithelial cells infected with influenza virus A and B and with respiratory syncytial virus (RSV)[J]. Biochemical Pharmacology,2011,82(5):548-555.
[52]Tekkanat K K, Maassab H F, Cho D S, et al. IL-13-induced airway hyperreactivity during respiratory syncytial virus infection is STAT6 dependent[J]. Journal of Immunology,2001,166(5):3542-3548.
[53]Li X M, Sun S Z, Wu F L, et al. Study on JNK/AP-1 signaling pathway of airway mucus hypersecretion of severe pneumonia under RSV infection[J]. European Review for Medical and Pharmacological Sciences,2016,20(5):853-857.
[54]Lee J W, Kim Y I, Im C N, et al. Grape seed proanthocyanidin inhibits mucin synthesis and viral replication by suppression of AP-1 and NF-kappaB via p38 MAPKs/JNK signaling pathways in respiratory syncytial virus-infected A549 cells[J]. Journal of Agricultural and Food Chemistry,2017,65(22):4472-4483.
[55]Schneider D, Hong J Y, Popova A P, et al. Neonatal rhinovirus infection induces mucous metaplasia and airways hyperresponsiveness[J]. Journal of Immunology,2012,188(6):2894-2904.
[56]Zhu L X, Lee P K, Lee W M, et al. Rhinovirus-induced major airway mucin production involves a novel TLR3-EGFR-dependent pathway[J]. American Journal of Respiratory Cell and Molecular Biology,2009,40(5):610-619.
[57]Kohri K, Ueki I F, Shim J J, et al. Pseudomonas aeruginosa induces MUC5AC production via epidermal growth factor receptor[J]. The European Respiratory Journal,2002,20(5):1263-1270.
[58]Li W, Yan F G, Zhou H B, et al. P. aeruginosa lipopolysaccharide-induced MUC5AC and CLCA3 expression is partly through Duox1 in vitro and in vivo[J]. PLoS One,2013,8(5):e63945.
[59]Lim J H, Kim H J, Komatsu K, et al. Differential regulation of Streptococcus pneumoniae-induced human MUC5AC mucin expression through distinct MAPK pathways[J]. American Journal of Translational Research,2009,1(3):300-311.
[60]Ha U H, Lim J H, Kim H J, et al. MKP1 regulates the induction of MUC5AC mucin by Streptococcus pneumoniae pneumolysin by inhibiting the PAK4-JNK signaling pathway[J]. The Journal of Biological Chemistry,2008,283(45):30624-30631.
[61]Sheng Y H, Hasnain S Z. Mucus and mucins:the underappreciated host defence system[J]. Frontiers in Cellular and Infection Microbiology,2022,12:856962.
[62]Samsuzzaman M, Uddin M S, Shah M A, et al. Natural inhibitors on airway mucin:molecular insight into the therapeutic potential targeting MUC5AC expression and production[J]. Life Sciences,2019,231:116485.
[63]Wang H Y, He L N, Liu B B, et al. Establishment and comparison of air-liquid interface culture systems for primary and immortalized swine tracheal epithelial cells[J]. BMC Cell Biology,2018,19(1):10.
[64]Silva S, Bicker J, Falcao A, et al. Air-liquid interface (ALI) impact on different respiratory cell cultures[J]. European Journal of Pharmaceutics and Biopharmaceutics,2023,184:62-82.